UnitedHealth Group has sued the U.S. government over its 2027 Medicare Advantage star ratings, escalating a fight that could reshape bonus payments on one of the insurer’s most important businesses and affect benefits for 7.61 million members.
UnitedHealth sues CMS over 2027 Medicare ratings

The lawsuit matters because the stars system is not just a branding exercise. Higher ratings can unlock government bonus payments worth hundreds of millions or even billions of dollars, while lower scores can force insurers to trim benefits, raise premiums or both.
In a complaint filed Thursday in federal court in Brunswick, Georgia, UnitedHealth said the Centers for Medicare & Medicaid Services improperly used 26 measures across 45 contracts and lacked statutory authority in parts of the scoring process. The company said the disputed ratings would rise by at least half a star, and as much as 1.5 stars, if CMS recalculated them properly.
UnitedHealth called the ratings the government’s “principal signal” of plan quality to patients. The Eden Prairie, Minnesota-based company said the lower scores could curb its ability to offer preventive care and make plans more expensive for seniors and disabled enrollees.
The suit lands as Medicare Advantage has become a bigger source of revenue and a sharper battleground for major insurers. UnitedHealth holds about 30% of the market, ahead of rivals including Humana and CVS Health, both of which have also challenged CMS ratings in court.
CVS sued last month, saying it could lose more than $2 billion in bonus payments and rebate retention, while Humana filed a similar case in 2024. A federal judge in Georgia previously ruled that CMS assigned an incorrect star rating to Clover Health and ordered a recalculation, and Judge Lisa Godbey Wood has been assigned to the new cases as well.
The litigation adds another layer of uncertainty for investors already watching how sharply Medicare funding and quality scores are hitting margins across the managed-care sector. UnitedHealth’s shares have fallen sharply in recent sessions, and the broader healthcare group has been under pressure amid a broader risk-off move in the market.
For UnitedHealth, the immediate issue is whether the court forces CMS back to the drawing board before the ratings feed into 2027 payments and plan design. For investors, the stakes are straightforward: star ratings can move earnings, membership and capital returns across the biggest U.S. Medicare Advantage carriers.
| Entity | Gains | Losses |
|---|---|---|
| UnitedHealth | ▲Higher star ratings, bonus payments | ▼Lower revenue, weaker margins |
| CMS | ▲Ratings process upheld | ▼Court challenge, legal scrutiny |
| CVS, Humana | ▲Potential precedent for recalculation | ▼Ongoing ratings and bonus pressure |
| Medicare members | ▲Better benefits if ratings improve | ▼Higher premiums if scores stay low |



